Medications for Mesothelioma Malignant

9 results

  • Axtle (pemetrexed)

    (pemetrexed)
    Avyxa Pharma, LLC
    Usage: AXTLE is indicated for the treatment of non-squamous non-small cell lung cancer (NSCLC) in combination with cisplatin, maintenance therapy after prior chemotherapy, and for recurrent NSCLC. It also treats unresectable malignant pleural mesothelioma in combination with cisplatin. Not for squamous NSCLC.

  • Pemetrexed (pemetrexed disodium)

    (PEMETREXED DISODIUM)
    Fresenius Kabi USA, LLC
    Usage: Pemetrexed for injection is indicated for the treatment of metastatic non-squamous non-small cell lung cancer (NSCLC) in combination with chemotherapy, as maintenance therapy, and for recurrent cases. Additionally, it is used with cisplatin for unresectable malignant pleural mesothelioma. Not for squamous cell NSCLC.

  • Pemetrexed (pemetrexed disodium)

    (Pemetrexed disodium)
    Accord Healthcare Inc.
    Usage: Pemetrexed Injection is indicated for the treatment of non-squamous non-small cell lung cancer (NSCLC) in combination with chemotherapy or as a maintenance therapy. It is also used with cisplatin for malignant pleural mesothelioma that is unresectable. Not indicated for squamous cell NSCLC.

  • Pemetrexed (pemetrexed disodium)

    (Pemetrexed disodium)
    NorthStar RxLLC
    Usage: Pemetrexed for Injection is indicated for the treatment of metastatic non-squamous non-small cell lung cancer (NSCLC) in combination with chemotherapy, for maintenance therapy, and for recurrent NSCLC post-chemotherapy. It is also indicated for malignant pleural mesothelioma in combination with cisplatin. Not for squamous cell NSCLC.

  • Pemetrexed (pemetrexed disodium)

    (Pemetrexed disodium)
    Biocon Pharma Inc.
    Usage: Pemetrexed for injection is indicated for the treatment of metastatic and locally advanced non-squamous non-small cell lung cancer (NSCLC) in combination with specific chemotherapy or as a maintenance and single-agent treatment. It is also indicated, with cisplatin, for malignant pleural mesothelioma. Not for squamous cell NSCLC.

  • Pemetrexed (pemetrexed)

    (Pemetrexed)
    Solco Healthcare US, LLC
    Usage: Pemetrexed is indicated for the treatment of non-squamous non-small cell lung cancer (NSCLC) in combination with chemotherapy or as a maintenance treatment. It is also used with cisplatin for malignant pleural mesothelioma in patients who cannot undergo surgery. Not indicated for squamous cell NSCLC.

  • Pemetrexed (pemetrexed)

    (Pemetrexed)
    Teva Pharmaceuticals Inc
    Usage: Pemetrexed Injection is indicated for the treatment of metastatic non-squamous non-small cell lung cancer (NSCLC) in combination with pembrolizumab or cisplatin, and for maintenance or recurrent NSCLC. It is also used with cisplatin for unresectable malignant pleural mesothelioma. Not indicated for squamous NSCLC.

  • Pemetrexed dipotassium (pemetrexed dipotassium)

    (pemetrexed dipotassium)
    Avyxa Pharma, LLC
    Usage: Pemetrexed for Injection is indicated for the treatment of non-squamous non-small cell lung cancer (NSCLC) in combination with cisplatin, as maintenance therapy, or for recurrent NSCLC. It is also indicated with cisplatin for malignant pleural mesothelioma when the disease is unresectable or surgery is not an option.

  • Pemetrexed disodium (pemetrexed)

    (Pemetrexed)
    Amneal Pharmaceuticals LLC
    Usage: Pemetrexed for injection is indicated for the initial treatment of non-squamous non-small cell lung cancer (NSCLC) in combination with chemotherapy or as a maintenance therapy post-chemotherapy. It is also indicated, with cisplatin, for treating unresectable malignant pleural mesothelioma. Not for use in squamous cell NSCLC.